A public benefit corporation for biomedical research and industry.

Computational and experimental cancer biologist who has spent his career on both sides of the bench: designing single-cell and multi-omic experiments in hematologic malignancies, then building the statistical and machine-learning methods that turn them into publishable results.

Formerly Assistant Professor at the Icahn School of Medicine at Mount Sinai, New York, and at Indiana University. Led genomics for multiple projects; author of the open-source single-cell pipelines that seed the Virtual Lab catalogue.

At BioMedsAI he sets the scientific direction, designs the QC and provenance standards behind every run, and signs the analyses the Virtual Lab delivers.

Computational biologist who builds, validates and operates clinical-grade DNA and RNA sequencing pipelines for oncology on Nextflow and HPC, from raw reads to curated variants.

Earlier work on gene-regulatory-network inference and multi-omic analysis at ETH Zurich, Columbia University and the Helmholtz Zentrum Munich; contributor to AACR GENIE variant curation. PhD, ETH Zurich.

Precision-oncology commercial leader with more than seven years bringing molecular and MRD testing into academic cancer centers, community oncology networks and integrated health systems.

Experience spans companion diagnostics, CAR-T launch, molecular tumor boards and EMR workflow integration. Master's in Translational Medicine, University of Nebraska Medical Center.